The Scottish Government recognises that the prescribing of methadone, and all forms of OST, is a matter for clinicians in consultation with individuals and that the risks of prolonged use and any possible side effects are a matter for clinicians who are bound by professional codes and evidence-based UK-wide clinical guidance on this.The Scottish Government agreed with recommendations made by the Drug Deaths Taskforce who recommended that more choice should be available on the types of OST offered where appropriate and notes that a significant proportion of people have chosen to move from methadone and oral buprenorphine to long acting injectable buprenorphine since the introduction of the medication Assisted Treatment standards in May 2021.However, methadone remains a recommended, evidence-based first line option for clinicians and individuals according to independent codes and clinical guidance.